Research & Insights
September 25, 2023
Lazard Global Biopharmaceutical Leaders Study 2023
The biopharma industry continues to be challenged by increased equity market volatility, following a period of unprecedented optimism and interest from generalists during the COVID-19 pandemic.
Lazard Interim Secondary Market Report 2023
Lazard Interim Secondary Market Report 2023
Behind Schedule: The Corporate Effort to Fulfill Climate Obligations
The Lazard Climate Center paper, Behind Schedule: The Corporate Effort to Fulfill Climate Obligations, reviews the state and progress of carbon emission reduction commitments made by corporations, as well as potential consequences of falling behind on pledges.
